Risultati per: Prima terapia farmacologica per l’apnea notturna (OSAS)

Senza trasfusioni in utero, ripulito sangue della mamma

Colpisce 1 su 20.000-50.000 neonati maschi, cura con 1 infusione

Per 89% pazienti, dopo 3 anni. Locatelli, con una sola infusione

Per neoplasia a grandi cellule b recidivante o refrattaria

Sono rivolte alla medicina territoriale e ospedaliera per favorire un uso ottimale degli antibiotici

Sono rivolte alla medicina territoriale e ospedaliera per favorire un uso ottimale degli antibiotici

Sono rivolte alla medicina territoriale e ospedaliera per favorire un uso ottimale degli antibiotici

This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in the general adult population (I statement).

This JAMA Patient Page summarizes the US Preventive Services Task Force’s recommendations on screening for, and treatment of, obstructive sleep apnea in adults.

An association of extreme obesity with hypersomnolence was recognized in antiquity and described in the early 19th century in both medical texts and, most famously, in Dickens’ Posthumous Papers of the Pickwick Club. However, not until the first polysomnographic recordings of sleep and respiration were made in the 1960s was it recognized that apneas resulting from intermittent obstruction of the upper airway during sleep, causing hypoxemia and cortical arousal, contributed to the excessive sleepiness in these so-called “Pickwickian” patients. The term “obstructive sleep apnea syndrome” was coined the following decade, and it was soon recognized that intermittent partial airway obstruction during sleep, resulting in reduced airflow (hypopnea) without apnea, could result in an identical clinical syndrome.